Even in the absence of statistical differences in patients with CIN II and CIN III in the TNFR1 gene polymorphisms, we tested whether TNFR1 expressing cells were differently present in these patients. This evidence concerns the gene TNFRSF1A and uterine cervix carcinoma in situ.